双肼屈嗪

Dihydralazine

未知生产厂商

Dihydralazine is under investigation in clinical trial NCT00311974 (The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Dihydralazine is under investigation in clinical trial NCT00311974 (The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals).

适应症

用于治疗高血压或心力衰竭。

技术标识符

化学式: C₈H₁₀N₆
CAS 编号: 484-23-1
UNII ID: PCU411F5L6

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Method of controlling damage mediated by alpha, beta-unsaturated aldehydes
US 2006160848 A1申请人: BURCHAM PHILIP C优先权: 2002
US
Compound antihypertensive drug and preparation method thereof
CN 101548985 B申请人: FUPING LAI优先权: 2009
CN
治疗高血压的药物组合物及其制备方法
CN 103800367 B申请人: 上海上药信谊药厂有限公司优先权: 2012
CN
复方利血平氨苯蝶啶片及其制法
CN 104644641 B申请人: 华润双鹤药业股份有限公司优先权: 2015
CN
Pharmaceutical composition prepared from dihydralazine sulfate and medical application of pharmaceutical composition
CN 106146604 A申请人: HU YIQIONG优先权: 2016
CN
Antihypertensive medicine composition
CN 107773567 A申请人: KAMP PHARMACEUTICAL CO LTD优先权: 2016
CN
Compound reserpine pharmaceutical composition and preparation method thereof
CN 107913286 A申请人: CHANGZHOU PHARMACEUTICAL FACTORY CO LTD优先权: 2016
CN
Compound reserpine tablet for treating hypertension and preparation method thereof
CN 106619707 A申请人: NANJING KANGKAI BIOLOGICAL TECH CO LTD优先权: 2016
CN
Preparation method of compound reserpine tablets
CN 108743611 A申请人: CHANGZHOU PHARMACEUTICAL FACTORY CO LTD优先权: 2018
CN
一种复方硫酸双肼屈嗪制剂及其制备方法和应用
CN 109288836 B申请人: 常州制药厂有限公司优先权: 2018
CN

药物